Literature DB >> 7987110

Scenario analysis of the future of medicines.

H Leufkens1, F Haaijer-Ruskamp, A Bakker, G Dukes.   

Abstract

Planning future policy for medicines poses difficult problems. The main players in the drug business have their own views as to how the world around them functions and how the future of medicines should be shaped. In this paper we show how a scenario analysis can provide a powerful teaching device to readjust peoples' preconceptions. Scenarios are plausible, not probable or preferable, portraits of alternative futures. A series of four of alternative scenarios were constructed: "sobriety in sufficiency," "risk avoidance," "technology on demand," and "free market unfettered." Each scenario was drawn as a narrative, documented quantitatively wherever possible, that described the world as it might be if particular trends were to dominate development. The medical community and health policy markers may use scenarios to take a long term view in order to be prepared adequately for the future.

Entities:  

Mesh:

Year:  1994        PMID: 7987110      PMCID: PMC2541914          DOI: 10.1136/bmj.309.6962.1137

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  6 in total

1.  Prescribing in Europe--forces for change.

Authors:  D Taylor
Journal:  BMJ       Date:  1992-01-25

Review 2.  AIDS drugs & the pharmaceutical industry: a need for reform.

Authors:  M T Griffin
Journal:  Am J Law Med       Date:  1991

3.  Ethical and financial considerations in third-party support of investigational cancer therapies.

Authors:  F E Young
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

4.  Do doctors short-change old people?

Authors: 
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

5.  Scenario analysis of the future of medicines.

Authors:  P I Folb
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

6.  Evaluating drugs after their approval for clinical use.

Authors:  W A Ray; M R Griffin; J Avorn
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

  6 in total
  7 in total

Review 1.  Lifestyle medicines.

Authors:  D Gilbert; T Walley; B New
Journal:  BMJ       Date:  2000-11-25

Review 2.  Drug rationing in the UK National Health Service. Current status and future prospects.

Authors:  T Walley; A Haycox; S Barton
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

3.  A purchaser perspective of managing new drugs: interferon beta as a case study.

Authors:  T Walley; S Barton
Journal:  BMJ       Date:  1995-09-23

Review 4.  Lifestyle medicines and the elderly.

Authors:  Tom Walley
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Drug reimbursement: indicators of inappropriate resource allocation.

Authors:  Bernard Bégaud; Ulf Bergman; Hans-Georg Eichler; Hubert G M Leufkens; Peter J Meier
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

6.  Projection scenarios of body mass index (2013-2030) for Public Health Planning in Quebec.

Authors:  Ernest Lo; Denis Hamel; Yun Jen; Patricia Lamontagne; Sylvie Martel; Colin Steensma; Chantal Blouin; Russell Steele
Journal:  BMC Public Health       Date:  2014-09-25       Impact factor: 3.295

Review 7.  Using the scenario method in the context of health and health care--a scoping review.

Authors:  Horst Christian Vollmar; Thomas Ostermann; Marcus Redaèlli
Journal:  BMC Med Res Methodol       Date:  2015-10-16       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.